metallothionein has been researched along with Leukemia--Myelomonocytic--Acute* in 2 studies
2 other study(ies) available for metallothionein and Leukemia--Myelomonocytic--Acute
Article | Year |
---|---|
CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells.
CBF beta-SMMHC is expressed from the inv(16) chromosome in M4Eo AML. Mice lacking CBF subunits or expressing the CBF beta-SMMHC or AML1-ETO oncoproteins failed to develop definitive hematopoiesis. To investigate these effects on hematopoiesis, we expressed CBF beta-SMMHC from the metallothionein promoter, in both 32D cl3 myeloid cells and Ba/F3 B-lymphoid cells. Addition of zinc increased CBF beta-SMMHC levels more than tenfold, with higher levels evident in Ba/F3 lines. Levels obtained in 32D cl3 cells were similar to those of endogenous CBF beta. Indirect immunofluorescence revealed zinc-inducible speckled, nuclear staining in Ba/F3 cells and diffuse nuclear staining in 32D cl3 cells. CBF beta-SMMHC reduced endogenous CBF DNA-binding fivefold in both cell types, increased cell generation time 1.9-fold, on average, in 32D cl3 cells and 1.5-fold in Ba/ F3 cells and decreased tritiated thymidine incorporation into DNA correspondingly. CBF beta-SMMHC increased the proportion of cells in G1 1.7-fold, on average, in 32D cl3 and Ba/F3 cells, and decreased the proportion of cells in S phase by a similar degree. CBF beta-SMMHC induced a marked increase in hypophosphorylated Rb, but did not alter IL-3 Receptor alpha or beta subunit levels. Neither apoptosis nor 32D differentiation was induced by zinc in IL-3 in these lines. Induction of CBF beta-SMMHC in 32D cl3 cells did not inhibit their differentiation to neutrophils or their expression of myeloperoxidase mRNA in G-CSF, and did not produce an eosinophilic phenotype. Additional, proliferative genetic changes in M4eo AMLs might potentiate inhibition of differentiation by CBF beta-SMMHC by allowing its increased expression. Topics: Animals; Blotting, Western; Cell Differentiation; DNA-Binding Proteins; Fluorescent Antibody Technique, Indirect; G1 Phase; Granulocyte Colony-Stimulating Factor; Leukemia, Myelomonocytic, Acute; Lymphoma; Metallothionein; Mice; Myosins; Peroxidase; Receptors, Interleukin-3; Recombinant Fusion Proteins; Retinoblastoma Protein; S Phase; Transcription Factor AP-2; Transcription Factors; Zinc | 1997 |
The human metallothionein gene cluster is not disrupted in myelomonocytic leukemia.
The human metallothionein gene complex on chromosome 16 has been remapped to 16q13 using high-resolution in situ hybridization. The complex is not disrupted by the rearrangement breakpoint on the long arm of chromosome 16 in patients with myelomonocytic leukemia with abnormal eosinophils, as had been previously reported. The locus order on 16q is cen-MT-FRA16B-D16S4-inversion breakpoint-HP-tel. Topics: Blotting, Southern; Chromosome Banding; Chromosomes, Human, Pair 16; DNA; DNA Probes; Humans; Leukemia, Myelomonocytic, Acute; Metallothionein; Nucleic Acid Hybridization | 1990 |